NEU 0.95% $18.84 neuren pharmaceuticals limited

Missing a sales target is one thing. NEU royalty receipts are...

  1. 2,760 Posts.
    lightbulb Created with Sketch. 476
    Missing a sales target is one thing. NEU royalty receipts are all profit and largely still intact with an Acadia modest sales target miss.
    Acadia guidance for net sales in 2024 is still intact. A first sales milestone payment of US$50 million to Neuren is expected to be earned for 2024 on Daybue sales reaching US$250M.
    Things could be much worse.
    Kens
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$18.84
Change
-0.180(0.95%)
Mkt cap ! $2.404B
Open High Low Value Volume
$18.96 $19.06 $18.72 $3.495M 185.5K

Buyers (Bids)

No. Vol. Price($)
14 1308 $18.84
 

Sellers (Offers)

Price($) Vol. No.
$18.85 7 1
View Market Depth
Last trade - 14.28pm 12/06/2024 (20 minute delay) ?
Last
$18.84
  Change
-0.180 ( 0.13 %)
Open High Low Volume
$18.95 $19.02 $18.72 69710
Last updated 14.46pm 12/06/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.